Summary.-MSC-10 tumour cells (derived from a chemically induced pulmonary squamous-cell carcinoma in DBA/2 mice) were inoculated intramuscularly into thymectomized, X-irradiated isogeneic mice, either 48 h or 6 weeks after thymectomy and X-irradiation. Normal mice and immunologically reconstituted mice served as controls. A marked enhancement in frequency of tumour takes was observed in all groups of animals inoculated with tumour cells 48 h after whole-body X-irradiation, whether thymectomized, immunologically reconstituted or not. The TD50 decreased to less than 1/10 of that observed in unirradiated controls. When mice were inoculated with tumour cells 6 weeks after X-irradiation, the incidence of tumour takes was similar to that of unirradiated controls, including the thymectomized-irradiated group, which was still severely immunodeficient as measured by antibody formation and skin graft rejection. The experiments indicate that whole-body X-irradiation creates a condition that favours tumour cell survival or growth. This "permissive state" exists only shortly after X-irradiation and is not correlated with the host's level of immunocompetence.
we describe the immunological characteristics of a transplantable pulmonary squamous-cell carcinoma (MSC-10) originally induced in a DBA/2 mouse with 3-methylcholanthrene. We found it impossible to induce any detectable degree of transplantation immunity with a variety of immunization procedures (e.g., repeated immunization with X-irradiated tumour cells and/or by transplanitation-excision method) and concluded that this tumour was non-immunogenic (which is not to say that the tumour could not have antigens associated with it).
The original purpose of the studies presented here was to determine whether it was possible to detect any subtle immune reactivity against the tumour by comparing the frequency of tumour takes and growth rates in normal and thymectomized, X-irradiated, immunologically suppressed mice. Our studies yielded no indication of an immunological host anti-tumour response. Instead they produced strong evidence that frequency of tumour take (probably due to increased survival of tumour cells) is markedly enhanced in whole-body X-irradiated recipients, and that this enhancement is not mediated by an immunological mechanism. Similar findings and conclusions were recently reported by Peters (1975) with a spontaneous adenocarcinoma derived from a CBA mouse. We feel that this enhancing effect of X-irradiation on survival of tumour cells, if it also occurs in humans, might have to be considered when weighing the relative risks and benefits of X-irradiation in cancer therapy.
MATERIALS AND METHODS
Mice.-We used inbred male DBA/2 (H-2d) mice 8-10 weeks old at the start of the experiment. The animals were maintained in filter-top cages with free access to food and water.
Tumour.-The mouse squamous-cell carcinoma (MSC-10) used was originally induced in a male DBA/2 mouse by intra-tracheal injection of 3-methylcholanthrene (Nettesheim and Hammons, 1971) . The tumour line has been maintained by serial passages in the strain of origin. Some of the in vivo characteristics of this tumour line were reported recently (Williams and Nettesheim, 1973) . Frozen pools of tumour-cell suspensions from the 10th in vivo passage were used throughout our studies.
Tumour-cell inoculation. Billingham and Medawar (1951) . Skin from isogeneic donors was used for control grafts.
The animals were inspected daily from Day 8 on, and the condition of the grafts was recorded. The day of complete destruction of the grafts was taken as the time of graft rejection.
RESULTS
Effect of thymectomy and X-irradiation on host resistance to tumour transplantation Eight-to 10-week-old mice were thymectomized and given a single dose of 600 rad whole-body X-irradiation 2 weeks later. Sham-thymectomized, unirradiated mice served as controls. Forty-eight hours after X-irradiation, the experimental and control animals were inoculated i.m. with either 103 or 104 live MSC-10 tumour cells.
Results of this experiment are summarized in Fig The results of the tumour transplantation studies are summarized in Fig. 2 . All three X-irradiated groups showed a marked increase in the incidence of tumour take and mortality, even when the animals were reconstituted with spleen cells and had received thymus grafts.
Tumour growth rates (not shown) showed no consistent differences between groups. 3-1± 07 6-8 ± 0 4 8-6 ± 0-3 (6 weeks after irradiation) Undetectable Undetectable 6-4 i 03 7-6 ± 0-3 5-0 ± 04 6-0 ± 0-6 8-4 0-3 9-8 0-1 * 108 SRBC injected i.p. either 48 h or 6 weeks after exposure to whole-body X-irradiation. t 10 mice per treatment group. t 2 X 108 syngeneic spleen cells and a whole thymic graft within 24 h after X-irradiation. > 60 16-1 ± 05 14-5 + 0 9 12-3 ± 0-6 (6 weeks after irradiation) > 60 11-2 ± 0-6 12-4 ± 0-6 11-2 ± 0-6 * Grafts performed either 48 h or 6 weeks after exposure to whole-body X-irradiation. t 10 mice per group.
1 2 x 108 syngeneic spleen cells and a whole thymic graft within 24 h after X-irradiation.
In a subsequent study, similarly treated groups of mice were tested for immunocompetence and resistance to tumour transplantation 6 weeks after whole-body 7-1 ± 3-9 7-3 ± 6-4
Mean size of nodules (mm3 ± s.e.)
35 ± 11-0 30 ± 8 -7
* Thymectomized, X-irradiated mice and sham-operated controls were inoculated i.m. with 2 x 104 live MSC-10 tumour cells 6 weeks after exposure to 600 rad whole-body X-irradiation. Tumour-bearing legs were removed 4 weeks after inoculations. These mice were killed 4 weeks after surgery and the number and size of lung metastases were determined. t 20 mice per group.
X-irradiation and inoculation of immunocompetent cells. We chose a 6-week period between X-irradiation-reconstitution and testing to allow time for recovery. The results of this study are summarized in the lower halves of Tables I and II and in Fig. 3 . The immunological studies showed partial and complete recovery, respectively, of the haemagglutinin and the homograft-rejection response in all but the thymectomized X-irradiated mice. This latter group showed no signs of immunological recovery. The tumour transplantation studies however, show that all groups of animals have reacquired an almost normal degree of resistance to tumour-cell inoculation, namely that of unirradiated, sham-thymectomized, agematched controls (see Fig. 3 ). Only 40-50/ of the animals developed tumours. Tumour development was actually slightly retarded in groups that had received X-irradiation 6 weeks earlier.
Incidence of tumour metastases in immunosuppressed mice A total of 20 mice were thymectomized and subsequently exposed to 600 rad of whole-body X-irradiation. Six weeks after X-irradiation, a time when humoral as well as cellular immune competence is still severely suppressed (see Tables I and  II,) the above group of animals and agematched, sham-operated control animals were challenged with 2 x 104 live tumour cells given i.m. The tumour-bearing legs were removed 4 weeks after inoculation. After a further 4 weeks, all animals were killed. Their lungs were removed and fixed, and the number of metastatic nodules was established in cleared and stained lungs with a dissecting microscope (Yuhas, 1973) . The results (Table III) show that the incidence of tumour metastasis is not affected by the immunosuppressed state (no metastases were found in any organs other than the lungs.).
DISCUSSION
The lung squamous-cell carcinoma (MSC-10) is a highly metastatic malignant tumour displaying no, or very weak, immunogenicity, since it is incapable of producing humoral immunity (determined by indirect immunofluorescent antibody techniques and radioimmunoassays) or inducing tranplantation resistance in syngeneic hosts (demonstrated by transplantation-excision method and Winn neutralization tests; Jamasbi and Nettesheim (1977) . This study was concerned with the question of whether immunosuppression induced by thymectomy and whole-body X-irradiation would significantly affect survival and growth of cells from this tumour line in syngeneic hosts. The key findings are as follows:
(a) Animals treated with whole-body X-irradiation (with or without thymectomy) show marked decrease in resistance (or enhanced susceptibility), by a factor of , 10, to tumour-cell inoculation shortly after X-irradiation. host-resistance to tumour transplantation is impaired shortly after exposure to a sublethal dose of X-irradiation. However, at least in the case of poorly immunogenic tumours, this is not a result of X-rayinduced immune suppression, since this decreased resistance vanishes with time, even when the state of immunosuppression persists, as in thymectomized, Xirradiated mice.
Our findings confirm and extend those reported by Peters (1975) obtained with a late-transplant generation of tumour cells derived from a spontaneous adenocarcinoma. He showed that the TD50 was markedly reduced in whole-body, Xirradiated mice up to at least 4 days after X-irradiation, but was normal in mice made immunodeficient by thymectomy plus X-irradiation several months prior to inoculation of tumour cells. Laparotomy also reduced the TD50, but this effect was less reproducible, less striking, and lasted for only a few hours. Attempts to correlate this enhanced transplantability of tumour cells with increased plasma fibrinogen levels failed. Whether the increased incidence of artificial lung metastases, following irradiation of the lung and subsequent i.v. inoculation of tumour cells (e.g., van den Brenk et al., 1973; Withers and Milas, 1973) is the same or a related phenomenon is not certain. Withers and Milas (1973) interpreted this as an X-ray effect on the capillary bed of the lung.
It is possible that the X-ray enhancement of tumour-cell survival reported here might easily be overlooked in studies with more immunogenic tumours, since the immunosuppressive effect of X-irradiation would tend to overshadow the phenomenon. This may be the reason why this apparent non-immunological effect of Xirradiation has not been reported more frequently.
Whether or not the enhanced survival of tumour cells following X-irradiation, and the enhancement of metastases following surgical trauma (for discussion see Peters, 1975 ) are related phenomena is presently unclear. However, since cancer patients are commonly subjected to either or both procedures, it seems that further elucidation of the mechanisms involved is highly desirable.
